The objective of this project Optimize assessment was to understand the structure, scope, and quality of the vaccine supply chain for fee-based immunization services and to provide recommendations for strengthening management and monitoring the quality of the vaccine supply chain for fee-based immunization.

Publication date: April 2011

Region: Asia

This comprehensive assessment of the Georgian vaccine-preventable disease (VPD) surveillance system identifies major problems in the Georgian health system that limit the ability of current surveillance efforts to provide quality information to guide public health actions.

Publication date: 2002

Region: Eastern Europe

Health Systems Research Institute, in partnership with project Optimize, a PATH and World Health Organization collaboration, commissioned a study led by the Faculty of Pharmacy, Mahidol University, to better understand the vaccine supply chain system in Thailand and the challenges of implementing a streamlined vendor-managed inventory system.

Publication date: September 2011

Region: Asia

Final report from PATH to USAID Jakarta for the ASUH or Healthy Start for a Healthy Life program. From 2000-2003, PATH, in collaboration with the Indonesian Ministry of Health and other partners, galvanized the participation of communities and the health system in four of Indonesia's districts.

Author: Muller N; Palmer A; Tsu V

Publication date: 2003

Region: Asia

Childhood immunization is a major public health concern in Cambodia. A study of the knowledge, attitudes, and practices of communities and health workers was conducted to identify barriers to immunization and inform future information, education, and communication strategies.

Publication date: 2002

Region: Asia

The study highlighted in this project Optimize report uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus (HPV) vaccine presentations.

Publication date: August 2010

Region: Global

This fact sheet aims to raise awareness about breastfeeding to prevent and treat diarrhea. One in a set of introductory resources, it provides stakeholders and policymakers in the world’s poorest countries with crucial information on a proven intervention in the fight against diarrheal disease.

Publication date: January 2008

Region: Global

Part of series: Diarrheal disease fact sheets

Today, most health workers at the service‐delivery level in developing countries use paper‐based systems to track the individuals who have been vaccinated and the vaccines and other resources used during the process. Project Optimize, a World Health Organization and PATH collaboration, is working with the Albanian Institute of Public Health to develop and implement an immunization information system that will provide the type of high-quality, granular data that policymakers need.

Publication date: July 2012

Region: Global

This fact sheet describes how project Optimize and our partners, Agence de Médecine Préventive, United Nations Children’s Fund, and the Vaccine Modeling Initiative at University of Pittsburgh, are working with countries to model the impact of changes to vaccine logistics and supply systems on vaccine availability, using a powerful new modeling tool called HERMES.

Publication date: May 2012

Region: Global

Publication date: 2002

Region: Global

Publication date: 2004

Region: Asia

Author: Kane M; Lasher H

Publication date: 2002

Region: Global

Part of series: CVP Occasional Papers

This market assessment aims to increase the awareness of biotechnology and pharmaceutical companies worldwide about the opportunities and potential markets that exist for low-cost and effective vaccines against enterotoxigenic Escherichia coli (ETEC). In addition, it provides donors and commercial investors with a better understanding of the potential risks, rewards, and gaps in knowledge relative to these opportunities as they consider their own investment strategies. The resulting analysis demonstrates that ETEC vaccines may represent a moderate opportunity for industry investment with an estimated annual revenue potential of more than US$600 million ten years after global launch.

Publication date: March 2011

Region: Global

PATH’s key areas of work in cervical cancer prevention are described in depth in this 12-page publication.

Publication date: August 2008

Region: Global

This fact sheet provides an overview of PATH's work to prevent and treat cervical cancer in Vietnam, including human papillomavirus vaccine introduction research, vaccine demonstration, a screening and treatment pilot model, and advocacy.

Publication date: May 2011

Region: Asia

PATH’s HPV Vaccine: Evidence for Impact project is designed to strengthen the capacity of developing countries to prevent cervical cancer. We are collaborating with partners in India, Peru, Uganda, and Vietnam to explore the most acceptable strategies for vaccinating young adolescent girls against human papillomavirus.

Publication date: May 2010

Region: Global

This document outlines a landscape policy analysis that identified challenges and opportunities for prioritizing diarrheal disease in Malawi.

Publication date: November 2011

Region: Africa

This website about PATH’s China country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Asia

Part of series: PATH's program websites

Clinical trials are a critical source of data for decisions around vaccine development. This fact sheet provides information about the phases of clinical trials.

Publication date: October 2009

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH’s work to develop and deploy a software tool called Cold Chain Equipment Manager to help vaccination programs manage equipment requirements, forecast equipment needs, and generate procurement lists. It includes a function that enables countries to view the cost and logistical implications of potential programmatic changes through “what if” scenarios such as procedural changes or the introduction of a new vaccine.

Publication date: September 2012

Region: Global

Part of series: Technology Updates